Literature DB >> 19409594

Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.

James O'Beirne1, Jon Mitchell, Farzin Farzaneh, Phillip M Harrison.   

Abstract

Hepatitis C virus core (HCVcore) protein was expressed in myeloid dendritic cells (DC) from C57/B6 mice (H-2K(b)) by electroporation of HCVcore mRNA to investigate its effect on the ability of DC to prime CD8+ T cells displaying a T cell receptor specific for OVA(257-264) peptide (SIINFEKL)/H-2K(b) complex. Expression of full length HCVcore(191), which is directed to the endoplasmic reticulum (ER) membrane by a C-terminal signal sequence, but not a truncated variant HCVcore(152), which has a wider subcellular localization including the nucleus, significantly reduced surface levels of the H-2K(b)/SIINFEKL complex and impaired the ability of DC to prime naïve CD8+ T cells when they had to process endogenous antigen but not when MHC class I molecules were loaded directly with SIINFEKL peptide. Exploitation of the MHC class I antigen-processing pathway by HCVcore(191) impairs the ability of DC to stimulate CD8+ T cells and may contribute to the persistence of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409594     DOI: 10.1016/j.virol.2009.03.035

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Cross-presentation of antigen by diverse subsets of murine liver cells.

Authors:  Mohammad R Ebrahimkhani; Isaac Mohar; Ian N Crispe
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

Review 2.  Dendritic cell-based immunity and vaccination against hepatitis C virus infection.

Authors:  Yun Zhou; Ying Zhang; Zhiqiang Yao; Jonathan Patrick Moorman; Zhansheng Jia
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.

Authors:  Michael K Connolly; Andrea S Bedrosian; Jon Mallen-St Clair; Aaron P Mitchell; Junaid Ibrahim; Andrea Stroud; H Leon Pachter; Dafna Bar-Sagi; Alan B Frey; George Miller
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

Review 4.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

Review 5.  Humanized Mouse Models for the Study of Hepatitis C and Host Interactions.

Authors:  Kylie Su Mei Yong; Zhisheng Her; Qingfeng Chen
Journal:  Cells       Date:  2019-06-17       Impact factor: 6.600

Review 6.  Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer.

Authors:  Isabella Lurje; Linda Hammerich; Frank Tacke
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

Review 7.  In the Crosshairs: RNA Viruses OR Complement?

Authors:  Nisha Asok Kumar; Umerali Kunnakkadan; Sabu Thomas; John Bernet Johnson
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 8.  Complement Evasion Strategies of Viruses: An Overview.

Authors:  Palak Agrawal; Renuka Nawadkar; Hina Ojha; Jitendra Kumar; Arvind Sahu
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

9.  HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.

Authors:  Xiaotian Song; Zhiyan Yao; Jianling Yang; Zhengzheng Zhang; Yuqing Deng; Miao Li; Cuiqing Ma; Lijuan Yang; Xue Gao; Wenjian Li; Jianguo Liu; Lin Wei
Journal:  Oncotarget       Date:  2016-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.